Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Cash from Investing Activities (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Cash from Investing Activities for 16 consecutive years, with -$1.4 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 86.86% to -$1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$34.3 million through Dec 2025, up 91.52% year-over-year, with the annual reading at -$34.3 million for FY2025, 91.52% up from the prior year.
  • Cash from Investing Activities hit -$1.4 million in Q4 2025 for Ani Pharmaceuticals, up from -$6.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $8.9 million in Q1 2024 to a low of -$398.5 million in Q3 2024.
  • Historically, Cash from Investing Activities has averaged -$28.9 million across 5 years, with a median of -$4.7 million in 2023.
  • Biggest YoY gain for Cash from Investing Activities was 479.64% in 2024; the steepest drop was 8652.95% in 2024.
  • Year by year, Cash from Investing Activities stood at -$82.2 million in 2021, then soared by 96.18% to -$3.1 million in 2022, then tumbled by 52.1% to -$4.8 million in 2023, then crashed by 123.5% to -$10.7 million in 2024, then surged by 86.86% to -$1.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for ANIP at -$1.4 million in Q4 2025, -$6.2 million in Q3 2025, and -$6.9 million in Q2 2025.